Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.
Pract Radiat Oncol
; 3(2 Suppl 1): S3-4, 2013.
Article
in En
| MEDLINE
| ID: mdl-24674539
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pract Radiat Oncol
Year:
2013
Document type:
Article